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Abstract The primary aim of this study was to evaluate the
frequency and seasonality of norovirus infection in hospi-
talized Polish children under 5 years of age, and a
secondary aim was to compare the clinical severity of
norovirus and rotavirus disease. The prospective surveil-
lance study was carried out from July 2009 through June
2010. Stool samples from 242 children hospitalized due to
acute viral gastroenteritis were tested for rotavirus group A
and adenovirus with commercial immunochromatographic
test and for norovirus with EIA assay. Single norovirus
infection was found in 35/242 (14.5%) patients and in a
further 5 (2.1%) children as co-infection with rotavirus.
Overall, norovirus was detected in 16.5% of stool speci-
mens. Norovirus infections tended to peak from October to
November and again from February to March. In autumn
months and in February, the proportion of norovirus
gastroenteritis cases was equal or even surpassed those of
rotavirus origin. Both norovirus and rotavirus infections most
commonly affected children between 12 and 23 months of
age. The low-grade or no fever was significantly more
common in children infected with norovirus (94.3%) com-
pared to rotavirus cases (52.9%). Overall, norovirus gastro-
enteritis was less severe than rotavirus disease with regard to
20-point severity scale (p<0.05). Noroviruses have emerged
as a relevant cause of acute gastroenteritis in Polish children.
There is a great need for introducing routine norovirus
testing of hospitalized children with gastroenteritis.
Introduction
Recently, norovirus gastroenteritis has been considered to
be second to rotavirus gastroenteritis as the cause of
children’s hospital admissions worldwide [1–4]. After
implementation of rotavirus vaccines into national immu-
nization programs in the years 2006 and 2007, the role of
norovirus gastroenteritis is expected to increase [5]. With
regard to the overview of recent literature, norovirus
gastroenteritis accounts for 6–48% of all acute gastroenter-
itis cases with an overall median of 14% [6]. Noroviruses
are small (27–35 nm in diameter), round-shaped, non-
capsulated particles which are transmitted from person to
person via the faecal-oral route, but droplet transmission
after vomiting episodes can also occur. The small infective
dose (<10 viral particles), long-time shedding, multiple
modes of transmission, wide genetic diversity of norovirus
strains, and resistance to the environmental factors make
them highly contagious [1, 7, 8]. Although norovirus
gastroenteritis is commonly regarded as a mild, short-
lasting intestinal disorder which resolves by itself, severe
dehydration and subsequent hospitalization are common
complications in very young and very old persons,
especially in those immunocompromised and with under-
lying diseases.
Due to the non-specific clinical manifestation, the
diagnosis of sporadic norovirus infection can be made by
detection of viral nucleic acid using reverse transcription-
polymerase chain reaction (RT-PCR) assays or by detection
of viral antigens in faeces using the enzyme linked
immunosorbent assays (ELISA) or the immunochromato-
graphic (ICG) tests [9–11]. Recently, RT-PCR has been
accepted as the “gold standard” in norovirus diagnostics,
whereas ELISA or ICG testing are suitable, relatively
inexpensive and rapid methods to determine norovirus
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necessary transmission-related precautions. In Poland, the
solid epidemiological data on sporadic and outbreak
norovirus infections are lacking due to the fact that
noroviruses are not routinely searched for in diagnostic
laboratories and, to date, there is no reference research
laboratory to determine the currently circulating strains.
The primary aim of this study was to determine the
frequency and seasonality of sporadic norovirus infections
in Polish children under 5 years of age hospitalized due to
the community-acquired, acute viral gastroenteritis in the
2009/2010 epidemic season and also to compare the clinical
severity of rotavirus and norovirus disease. The epidemic
season 2009/2010 is the third one since chargeable
rotavirus vaccines have been recommended to Polish
infants. In 2009, the rotavirus vaccination coverage in
northeastern Poland accounted for approximately 30% of
children up to 3 years of age.
Material and methods
Setting
The study was carried out in the 20-bed Department of
Paediatric Infectious Diseases at University Children’s Hospital
in Bialystok, Poland. The department is located in northeastern
Poland and provides inpatient care for children with acute
gastroenteritis who reside in Bialystok city and Bialystok
district. An estimated catchment population accounts for
approximately 8,200 children aged <5 years, representing
about 50% of all children aged <5 years in our region.
Material
All 373 children less than 5 years of age admitted to our
department due to the community-acquired, acute viral
gastroenteritis between July 2009 and June 2010 were
invited to participate in the study project. The acute viral
gastroenteritis was considered as abrupt onset of diarrhoea
(three or more episodes of watery stool in a period of 24 h)
and/or vomiting with or without fever. Inclusion criteria
were: age less than 5 years and informed consent obtained
from parents or legal guardians. Patients with diarrhoea of
over 7 days’ duration, an antibiotic treatment before
presentation, underlying diseases or confirmed bacterial
diarrhoea were excluded. Overall, 242 children were
enrolled in the study.
Methods
For each child, stool samples were collected within 36 hours
of admission. Rotavirus group A and adenovirus were tested
in fresh faecal specimens on a routine basis by means of
commercial, ICG assay (VIKIA Rota-Adeno, Biomerieux).
Then, the same stool samples for norovirus detection were
frozen and stored in <20°C for future simultaneous testing
with the IDEA™Norovirus (DakoCytomation; Oxoid, Ltd)
according to the manufacturer’s instruction.
To assess severity of illness the clinical data (duration
and frequency of diarrhoea and vomiting and the presence
of fever and dehydration) were determined. The severity of
gastrointestinal disease was estimated with the numerical
scoring system of Ruuska and Vesikari [12]. Rotavirus
immunization status was also recorded.
Statistical analysis was performed with Statistica StatSoft,
version 9. The Mann–Whitney U-test was used to compare
quantitative variables and chi-squared test for comparison of
proportions. All tests were two-tailed and the difference was
considered statistically significant when p<0.05.
The study was approved by the Research Ethical
Committee of the Medical University in Bialystok.
Results
During the one-year surveillance period a total of 242
children (114 males) with acute viral gastroenteritis were
enrolled. As we estimated, they accounted for approximately
3% of the catchment population. Nine out of 242 (3.7%)
children were vaccinated against rotavirus disease. Stool
samples obtained from enrolled children were tested for
enteric viruses. The causative agent of viral gastroenteritis
was detected in 105/242 (43.4%) cases. Single norovirus
infection was found in 35/242 (14.5%) patients, rotavirus in
51/242 (21.1%) and adenovirus in 14/242 (5.8%) patients.
Dual viral-viral co-infection was confirmed in a further 5/242
(2.1%)cases. To assessthe norovirus gastroenteritis burden in
Polish children, relative prevalence of major viral agents
norovirus, rotavirus group A and adenovirus was determined
in positive-tested faecal specimens.
Rotavirus group A was the most prevalent single agent
and was detected in 48.6% (51/105) of stool samples,
including one stool sample coming from a vaccinated child.
Norovirus was present in 33.3% (35/105) and adenovirus in
13.3% (14/105) of the specimens. Dual norovirus and
rotavirus infection was detected in 3.8% (4/105) of cases
and dual norovirus and adenovirus infection in one patient
(1%). Overall, norovirus was detected in 16.5% (40/242) of
the samples tested.
Although norovirus gastroenteritis cases were recorded
throughout the year, they tended to peak in autumn months
from September to November and again from January to
March (Fig. 1). In autumn months and in February, the
proportion of norovirus gastroenteritis cases was equal or
even surpassed those of rotavirus origin. Among 35
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(28/35) were hospitalized from October through March.
The median age of children infected with norovirus and
rotavirus was similar and accounted for 17 months (range
1–57) and 18 months (range 4–57), respectively. The age-
adjusted distribution of norovirus gastroenteritis cases
compared to rotavirus gastroenteritis cases is presented in
Fig. 2. The majority of norovirus infections was recorded in
children up to 2 years of age (74%). Both norovirus and
rotavirus infections most commonly affected children
between 12 and 23 months of age.
As we assessed, norovirus disease was similar to
rotavirus disease with regard to frequency and duration of
diarrhoea and vomiting (Table 1). The low-grade or no
fever was significantly more common in children infected
with norovirus (94.3%) compared to rotavirus cases
(52.9%). Overall, norovirus gastroenteritis was a less severe
disease than rotavirus disease with regard to the 20-point
severity scale (p<0.05).
Discussion
This study is the third one coming from our facility which
deals with norovirus infections in Polish children [13, 14].
After searching the recent polish literature adhering to this
topic, we found only one study based on data coming from
a routine surveillance system on foodborne and waterborne
norovirus outbreaks in Poland [15]. Recently, many reports
have established the importance of noroviruses as a cause
of outbreaks [16–18]. Community-acquired, sporadic cases
of norovirus gastroenteritis have been known to a much less
extent since individual cases are poorly diagnosed and
Fig. 1 Monthly distribution of
norovirus (NV) and rotavirus
(RV) cases (a), and proportions
(b) in enrolled children. The
black bars indicate norovirus
cases; empty bars indicate
rotavirus cases
Fig. 2 Age-adjusted distribution of norovirus (NV; black bars) and
rotavirus (RV; empty bars) infections in enrolled children
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are not covered by routine analysis of stool samples from
patients with gastroenteritis, and therefore the problem of
norovirus infections has been underappreciated. However, as
we have documented in the present study, the incidence of
single norovirus gastroenteritis in Polish children under
5 years of age is relatively high and accounts for 14.5% of
all hospitalized acute gastroenteritis cases and for 33.3% of
those of specified aetiology. The norovirus positivity rate in
hospitalized Polish children increased by 3% compared to the
results of our pilot study performed in 2005 [13]. It is likely
that the observed increase in relative frequency of norovirus
gastroenteritis cases is due to implementing a rotavirus
vaccination in Polish infants since the 2006–2007 epidemic
season. Patel et al. [4], reviewing the results of recent studies
in which molecular methods were applied for detection of
enteric viruses, showed that noroviruses accounted for
approximately 12% (range 4.4–30.7%) of severe gastro-
enteritis cases among children <5 years of age world-
wide. In turn, Koopman [6], searching the recent literature
results for prevalence of norovirus in hospitalized children
with acute gastroenteritis across the world, calculated the
median value at the level of 14%. To our knowledge, the
lowest prevalence of sporadic norovirus gastroenteritis in
European children was recorded in Hungary [19]a t6 . 5 % ,
whereas the highest were in Italy [20] at 39.2% and in
Finland [5] at 29%. Observed discrepancies in frequency
of norovirus disease need to be interpreted with caution.
Many factors such as study design and duration, age of
patients, epidemic season or methods applied may influ-
ence the final results. The IDEA enzyme immunoassay
applied in this study is considered as highly specific for
some noroviruses, but generally not sensitive enough to
detect a wide range of noroviruses [9, 10]. Assuming that
Clinical symptoms Score NV, n=35; (%) RV, n =51; (%) p value
Duration of diarrhea (days)
0 0 0 0 0.17
1–4 1 30 (85.7)3 5 ( 68.6)
5 2 1 (2.9) 5 (9.8)
≥6 3 4 (11.4) 11 (21.6)
Diarrhea episodes/24 h
0 0 0 0 0.09
1 1 16 (45.7) 12 (23.5)
2 2 10 (28.6) 22 (43.1)
≥3 3 9 (25.7) 17 (33.4)
Duration of vomiting (days)
No vomiting 0 1 (2.8) 5 (9.8) 0.13
1 1 15 (42.9)1 9 ( 37.3)
2 2 12 (34.3) 9 (17.6)
≥3 3 7 (20.0) 18 (35.3)
Vomiting episodes/24 h
No vomiting 0 1 (2.8) 5 (9.8) 0.15
1 1 6 (17.1) 4 (7.8)
2–4 2 15 (42.9)3 0 ( 58.8)
≥5 3 13 (37.1) 12 (23.6)
Fever (°C)
<37.0 0 25 (71.4)1 5 ( 29.4) 0.002
37.1–38.4 1 8 (22.9) 12 (23.5)
38.5–38.9 2 2 (5.7) 13 (25.5)
≥39.0 3 0 11 (21.6)
Dehydration
None 0 0 0 0.40
1–5% 2 35 (100)5 0 ( 98.0)
≥6% 3 0 1 (2.0)
Severity score
a
Mild 0–7 0 1 (2.0) 0.01
Moderate 8–13 30 (85.7)2 8 ( 54.9)
Severe 14–20 5 (14.3) 22 (43.1)
Table 1 Clinical manifestation
of norovirus (NV) and
rotavirus (RV) infections
according to 20-point severity
score [12]
aAll children were hospitalized
and therefore received an
extra 2 points
Figures in bold highlight the
highest value
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norovirus in samples collected in sporadic cases of
gastroenteritis ranges from 44.6 to 75.9% [9], the real
incidence of norovirus gastroenteritis in the present study
is expected to be higher. Our results confirm the relevance
of norovirus second to rotavirus as the cause of severe
gastroenteritis in young Polish children. A limitation of
the recent study is the lack of the possibility to determine
the molecular characteristics of circulating norovirus
strains.
In the present study, norovirus gastroenteritis cases were
detected all year round, except July. We observed two peak
waves, one in September–October and the second one from
January to March. The same seasonality pattern was
observed in our previous study [13]. Norovirus infections
preceded the epidemic increase of rotavirus cases by two
months. Similar regularity concerning winter predominance
of norovirus infections was observed by many in previous
studies [5, 20–23].
The overall severity score was significantly lower for
norovirus infection compared to rotavirus gastroenteritis
cases. This is probably due to a lower frequency of high-
grade fever and evacuations in norovirus infected
children. Similar results were found by Junquera et al.
[3] in Spain and by Narkeviciute and Tamusauskaite [24]
in Lithuania.
In conclusion, in light of recent findings, noroviruses
have emerged as a relevant cause of acute, community-
acquired gastroenteritis in Polish children. There is a great
need for introducing the routine norovirus testing in
hospitalized patients with gastroenteritis and to find at least
one National Virus Reference Laboratory to recognize the
real burden as well as molecular epidemiology of viral
intestinal infections in the Polish childhood population.
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